Latest Nasdaq Listings News

Chilwa Minerals confirmed a significant niobium discovery at its Nakombe target, progressing with dual diamond rig drilling and advancing a NASDAQ listing application. Heavy mineral sands resource work continues alongside a new ionic clay rare earth program.

Resolution Minerals has successfully produced high-grade tungsten concentrates from historical stockpiles at its Golden Gate mine, achieving a 19-fold upgrade and strong recovery rates using simple gravity separation techniques.

American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.

American Rare Earths is fast-tracking its Wyoming Halleck Creek rare earths project, defining a pilot plant pathway, advancing oxide to metal studies, and targeting a NASDAQ listing by year-end 2026.

CLINUVEL Pharmaceuticals has received final scientific advice from the European Medicines Agency on the design of its pivotal Phase III trial for SCENESSE in vitiligo, endorsing a comprehensive evidence approach and prioritising patients with darker skin tones.

Resolution Minerals has raised A$20 million in a strongly supported institutional placement to accelerate exploration and development at its US Horse Heaven Project, while preparing for a NASDAQ listing to boost its US market presence.

Nova Minerals has secured ASIC registration of its Scheme Booklet for re-domiciling to the US, alongside amendments to warrant terms that triple warrant exchange ratios ahead of the move.

Jindalee Lithium is set to list its McDermitt lithium project on NASDAQ through a US SPAC deal valuing the assets at US$571 million, while securing key US federal approvals and advancing magnesium by-product potential.

Aurora Energy Metals has completed the sale of its Aurora Uranium Project to Eagle Nuclear Energy, receiving US$17.1 million in equity and holding rights to up to US$10 million in milestone payments plus a 1% royalty. The transaction strengthens Aurora's balance sheet and ushers in a new leadership phase.

Resolution Minerals has appointed seasoned mining executive Brett Lynch as a non-executive director to bolster its U.S. growth strategy ahead of a NASDAQ listing. Lynch’s proven North American critical minerals expertise aligns with the company’s ambitions at its Horse Heaven project in Idaho.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Veris Limited has expanded its relationship with Hexagon’s Octave by becoming the authorised geospatial software distributor across Australia and New Zealand, aiming to generate an initial $1.2 million in annual recurring revenue.